Podrobná bibliografie
| Název: |
Terlipressin use in hepatorenal syndrome—acute kidney injury in cirrhosis. Author's reply. |
| Autoři: |
Nadim, Mitra K., Forni, Lui G., Ostermann, Marlies |
| Zdroj: |
Intensive Care Medicine; Jan2025, Vol. 51 Issue 1, p215-216, 2p |
| Témata: |
INFUSION therapy, ACUTE kidney failure, HYPERVOLEMIA, BOLUS drug administration, PULMONARY edema |
| Abstrakt: |
The article discusses the use of terlipressin in hepatorenal syndrome-acute kidney injury in cirrhosis, based on recommendations from physicians in nephrology, hepatology, and critical care. The decision to remove albumin from the diagnostic criteria of HRS-AKI was made to avoid potential harm from a one-size-fits-all approach to fluid administration. The article also addresses concerns about the use of terlipressin, emphasizing the need for careful monitoring and individualized treatment. The authors recommend terlipressin as the first-line vasoconstrictor for HRS-AKI, despite limitations in existing studies comparing terlipressin and norepinephrine. [Extracted from the article] |
|
Copyright of Intensive Care Medicine is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Databáze: |
Complementary Index |
Full Text Finder 
Nájsť tento článok vo Web of Science